204 related articles for article (PubMed ID: 24971320)
1. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
2. CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Chou YE; Hsieh MJ; Hsin CH; Chiang WL; Lai YC; Lee YH; Huang SC; Yang SF; Lin CW
PLoS One; 2014; 9(4):e93692. PubMed ID: 24699672
[TBL] [Abstract][Full Text] [Related]
3.
Pan X; Li M; Huang L; Mo D; Liang Y; Huang Z; Zhu B; Fang M
Biomed Res Int; 2020; 2020():2918517. PubMed ID: 33062675
[TBL] [Abstract][Full Text] [Related]
4. Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
Weng WC; Huang YH; Yang SF; Wang SS; Kuo WH; Hsueh CW; Huang CH; Chou YE
Tumour Biol; 2016 May; 37(5):6971-7. PubMed ID: 26662954
[TBL] [Abstract][Full Text] [Related]
5. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population.
Deng Y; Chen ZJ; Lan F; He QT; Chen SY; Du YF; Li S; Qin X
J Clin Lab Anal; 2019 Oct; 33(8):e22977. PubMed ID: 31301090
[TBL] [Abstract][Full Text] [Related]
6. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
7. Effects of EZH2 polymorphisms on susceptibility to and pathological development of hepatocellular carcinoma.
Yu YL; Su KJ; Hsieh YH; Lee HL; Chen TY; Hsiao PC; Yang SF
PLoS One; 2013; 8(9):e74870. PubMed ID: 24040354
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.
Huang WS; Lin HY; Yeh CB; Chen LY; Chou YE; Yang SF; Liu YF
Int J Med Sci; 2017; 14(2):136-142. PubMed ID: 28260989
[TBL] [Abstract][Full Text] [Related]
9. Association of CD44 gene rs187115 polymorphism with colorectal cancer risk and prognosis in Chinese Han population: a case-control study.
Wan Q; Zhang D; Zhou Q; Li M; Wang Y; Song Y; Xu T
Aging (Albany NY); 2019 Nov; 11(21):9616-9625. PubMed ID: 31682231
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
Sheu MJ; Hsieh MJ; Chiang WL; Yang SF; Lee HL; Lee LM; Yeh CB
PLoS One; 2015; 10(4):e0122961. PubMed ID: 25860955
[TBL] [Abstract][Full Text] [Related]
11. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive study of CD44 rs 187115 variant and cancer risk in a central Chinese population.
Chen B; Yi C; Wang J; Wang J; Zhang J; Gu X; Feng X
J Cell Biochem; 2019 Aug; 120(8):12949-12957. PubMed ID: 30860617
[TBL] [Abstract][Full Text] [Related]
13. Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma.
Wang B; Yeh CB; Lein MY; Su CM; Yang SF; Liu YF; Tang CH
Int J Med Sci; 2016; 13(4):304-9. PubMed ID: 27076788
[TBL] [Abstract][Full Text] [Related]
14. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development.
Hsieh MC; Hsu HT; Hsiao PC; Yang SF; Yeh CB; Bien MY; Lin CH; Chien MH
J Clin Lab Anal; 2014 May; 28(3):237-44. PubMed ID: 24478168
[TBL] [Abstract][Full Text] [Related]
15. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
16. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
Huang YL; Wu JR; Fang M; Zhao HL; Liu ZM; Ye J; Huang LS; Zhu B
Medicine (Baltimore); 2019 Apr; 98(14):e15090. PubMed ID: 30946366
[TBL] [Abstract][Full Text] [Related]
17. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
18. Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Wang B; Hsu CJ; Lee HL; Chou CH; Su CM; Yang SF; Tang CH
Int J Med Sci; 2018; 15(6):653-658. PubMed ID: 29725257
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic value of CD44 gene polymorphism (rs187115) in Swedish patients with colorectal cancer.
Nguyen SV; Shamoun L; Landerholm K; Wågsäter D; Dimberg J
Nucleosides Nucleotides Nucleic Acids; 2023; 42(10):807-817. PubMed ID: 37074032
[TBL] [Abstract][Full Text] [Related]
20. A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.
Liu F; Luo L; Liu Z; Wu S; Zhang W; Li Q; Peng Y; Wei Y; Li B
Mol Carcinog; 2020 Nov; 59(11):1243-1255. PubMed ID: 32869896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
